Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Naldemedine (Rizmoic®)	TA651 - Naldemedine for treating opioid-induced constipation
Naloxegol (Moventig®)	TA345 - Naloxegol for treating opioid-induced constipation	For treating opioid-induced chronic constipation - use in line with NICE
Naloxone
Naproxen tablets
Naseptin nasal cream		Contains arachis (peanut oil)
Nebulised hypertonic sodium chloride (Resp-Ease)		Resp-Ease (Sodium Chloride 7% nebuliser solution) for CF patients
Neodocromil sodium 2% eye drops
Nexplanon (Etonogestral) 68mg implant		Umbrella service only
Nicorette patches
Nicotine replacement chewing gum

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.